United Nations Office on Drugs and Crime (UNODC). World drug report 2016. New York: United Nations Publication; 2016 [Accessed 26 July 2017] p. 174. http://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf.
Iversen LL. The science of marijuana. Br J Clin Pharmacol. 2009;67:268.
Article
Google Scholar
Center for Behavioral Health Statistics and Quality. 2015 National survey on drug use and health: detailed tables prevalence estimates. 2016. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf.
Substance Abuse and Mental Health Services Administration. Results from the 2011 national survey on drug use and health: summary of national findings, NSDUH series H-44, HHS publication no. (SMA) 12-4713. Rockville, Maryland: Substance Abuse and Mental Health Services Administrations, 2012.
Jouanjus E, Raymond V, Lapeyre-Mestre M, Wolff V. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr Atheroscler Rep. 2017;19:26.
PubMed
Article
Google Scholar
Booth JK, Page JE, Bohlmann J. Terpene synthases from Cannabis sativa. PLoS One. 2017;12:e0173911.
PubMed
PubMed Central
Article
CAS
Google Scholar
Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D. Efficacy and safety of medical marijuana in selected neurologic disorders. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82:1556–63.
PubMed
PubMed Central
Article
Google Scholar
Iversen L. Cannabis and the brain. Brain. 2003;126:1252–70.
PubMed
Article
Google Scholar
Ohlsson A, Lindgren JE, Wahlen A, et al. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther. 1980;28:409–16.
PubMed
Article
CAS
Google Scholar
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327–60.
PubMed
Article
CAS
Google Scholar
Gurney SMR, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:53–78.
PubMed
CAS
Google Scholar
Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther. 1979;25:440–6.
PubMed
Article
CAS
Google Scholar
Gash A, Karliner JS, Janowsky D, Lake CR. Effects of smoking marihuana on left ventricular performance and plasma norepinephrine studies in normal men. Ann Intern Med. 1978;89:448–52.
PubMed
Article
CAS
Google Scholar
Kanakis C Jr, Pouget JM, Rosen KM. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation. 1976;53:703–7.
PubMed
Article
CAS
Google Scholar
Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking: cardiovascular effects in man and possible mechanisms. Ν Engl J Med. 1972;287:209–12.
Article
CAS
Google Scholar
Sulkowski A, Vachon L, Rich E. Propranolol effects on acute marihuana intoxication in man. Psychopharmacology. 1977;52:47–53.
PubMed
Article
CAS
Google Scholar
Huestis MA, Boyd SJ, Heishman SJ, Preston KL. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology. 2007;194:505–15.
PubMed
PubMed Central
Article
CAS
Google Scholar
Karschner EL, Darwin WD, McMahon RP, Liu F, Wright S, Goodwin RS, et al. Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther. 2011;89:400–7.
PubMed
Article
CAS
Google Scholar
Jicha CJ, Lofwall MR, Nuzzo PA, Babalonis S, Elayi SC, Walsh SL. Safety of oral dronabinol during opioid withdrawal in humans. Drug Alcohol Depend. 2015;157:179–83.
PubMed
PubMed Central
Article
CAS
Google Scholar
Charbonney E, Sztajzel JM, Poletti PA, Rutschmann O. Paroxysmal atrial fibrillation after recreational marijuana smoking: another “holiday heart”? Swiss Med Wkly. 2005;135:412–4.
PubMed
Google Scholar
Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association. Int J Cardiol. 2001;78:183–4.
PubMed
Article
CAS
Google Scholar
Singh GK. Atrial fibrillation associated with marijuana use. Pediatr Cardiol. 2000;21:284.
PubMed
Article
CAS
Google Scholar
Ponto LL, O’Leary DS, Koeppel J, et al. Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: effect in occasional and chronic users. J Clin Pharmacol. 2004;44:751–66.
PubMed
Article
CAS
Google Scholar
Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005–2012. J Hypertens. 2016;34:1507–12.
PubMed
PubMed Central
Article
CAS
Google Scholar
Prakash R, Aronow WS, Warren M, et al. Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease. Clin Pharmacol Ther. 1975;18:90–5.
PubMed
Article
CAS
Google Scholar
Tashkin DP, Levisman JA, Abbasi AS, Shapiro BJ, Ellis NM. Short-term effects of smoked marihuana on left ventricular function in man. Chest. 1977;72:20–6.
PubMed
Article
CAS
Google Scholar
Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–51.
PubMed
Article
CAS
Google Scholar
Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med. 1974;291:65–7.
PubMed
Article
CAS
Google Scholar
Baranchuk A, Johri AM, Simpson CS, Methot M, Redfearn DP. Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report. Cases J. 2008;1:373.
PubMed
PubMed Central
Article
Google Scholar
Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, Meng ID, Julius D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature. 2004;427:260–5.
PubMed
Article
CAS
Google Scholar
Dines AM, Wood DM, Galicia M, Yates CM, Heyerdahl F, Hovda KE, et al. Presentations to the emergency department following cannabis use—a multi-centre case series from ten European countries. J Med Toxicol. 2015;11(4):415–21.
PubMed
PubMed Central
Article
Google Scholar
O’Sullivan SE, Kendall DA, Randall MD. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. J Pharmacol Exp Ther. 2006;317:428–38.
PubMed
Article
CAS
Google Scholar
Quercioli A, Pataky Z, Vincenti G, et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J. 2011;32:1369–78.
PubMed
Article
CAS
Google Scholar
Lipina C, Hundal HS. Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol. 2016;6:150276.
PubMed
PubMed Central
Article
CAS
Google Scholar
Williams JC, Klein TW, Goldberger BA, Sleasman JW, Mackman N, Goodenow MM. Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. J Inflamm (Lond). 2015;12:39.
Article
CAS
Google Scholar
Dahdouh Z, Roule V, Lognoné T, Sabatier R, Grollier G. Cannabis and coronary thrombosis: what is the role of platelets? Platelets. 2012;23:243–5.
PubMed
Article
CAS
Google Scholar
Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a young man with normal coronary arteries. J Emerg Med. 2014;47:277–81.
PubMed
Article
Google Scholar
Velibey Y, Sahin S, Tanık O, Keskin M, Bolca O, Eren M. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med. 2015;33:1114.e1–3.
Article
Google Scholar
Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg. 2004;99:1127–30.
PubMed
Article
CAS
Google Scholar
Brantl SA, Khandoga AL, Siess W. Mechanism of platelet activation induced by endocannabinoids in blood and plasma. Platelets. 2014;25:151–61.
PubMed
Article
CAS
Google Scholar
Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.
PubMed
PubMed Central
Article
Google Scholar
Lindsay AC, Foale RA, Warren O, Henry JA. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol. 2005;104:230–2.
PubMed
Article
Google Scholar
Rezkalla S, Kloner RA. Recreational marijuana use: is it safe for your patient? J Am Heart Assoc. 2014;3:e000904.
PubMed
PubMed Central
Article
Google Scholar
Rezkalla S, Stankowski R, Kloner RA. Cardiovascular effects of marijuana. J Cardiovasc Pharmacol Ther. 2016;21:452–5.
PubMed
Article
CAS
Google Scholar
Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805–9.
PubMed
Article
CAS
Google Scholar
Nawrot TS, Perez L, Künzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011;377:732–40.
PubMed
Article
Google Scholar
Safaa AM, Markham R, Jayasinghe R. Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev. 2012;31:91–4.
PubMed
Article
Google Scholar
Caldicott DG, Holmes J, Roberts-Thomson KC, Mahar L. Keep off the grass: marijuana use and acute cardiovascular events. Eur J Emerg Med. 2005;12:236–44.
PubMed
Article
Google Scholar
Tatli E, Yilmaztepe M, Altun G, et al. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man. Int J Cardiol. 2007;120:420–2.
PubMed
Article
Google Scholar
Cappelli F, Lazzeri C, Gensini GF, et al. Cannabis: a trigger for acute myocardial infarction? A case report. J Cardiovasc Med (Hagerstown). 2008;9:725–8.
Article
Google Scholar
Yurtdaş M, Aydın MK. Acute myocardial infarction in a young man; fatal blow of the marijuana: a case report. Korean Circ J. 2012;42:641–5.
PubMed
PubMed Central
Article
Google Scholar
Pratap B, Korniyenko A. Toxic effects of marijuana on the cardiovascular system. Cardiovasc Toxicol. 2012;12:143–8.
PubMed
Article
Google Scholar
Arora S, Goyal H, Aggarwal P, Kukar A. ST-segment elevation myocardial infarction in a 37-year-old man with normal coronaries—it is not always cocaine! Am J Emerg Med. 2012;30:2091.e3.
Google Scholar
Karabulut A, Cakmak M. ST segment elevation myocardial infarction due to slow coronary flow occurring after cannabis consumption. Kardiol Pol. 2010;68:1266–8.
PubMed
Google Scholar
Casier I, Vanduynhoven P, Haine S, Vrints C, Jorens PG. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol. 2014;69:131–6.
PubMed
Article
Google Scholar
Gunawardena MDVM, Rajapakse S, Herath J, Amarasena N. Myocardial infarction following cannabis induced coronary vasospasm. BMJ Case Rep. 2014;2014. https://doi.org/10.1136/bcr-2014-207020.
PubMed
PubMed Central
Article
Google Scholar
Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128:e1622–7.
PubMed
Article
Google Scholar
Atik SU, Dedeoglu R, Varol F, Cam H, Eroglu AG, Saltik L. Cardiovascular side effects related with use of “bonzai”: two case reports. Turk Arch Pediatr. 2015;50:61–4.
Article
Google Scholar
McKeever RG, Vearrier D, Jacobs D, LaSala G, Okaneku J, Greenberg MI. K2—not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report. J Am Coll Med Toxicol. 2015;11:129–31.
Article
Google Scholar
Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(11 Suppl):58S–63S.
PubMed
Article
CAS
Google Scholar
Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–6.
PubMed
Article
CAS
Google Scholar
Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med. 2003;42:365–9.
PubMed
Article
Google Scholar
Basnet S, Mander G, Nicolas R. Coronary vasospasm in an adolescent resulting from marijuana use. Pediatr Cardiol. 2009;30:543–5.
PubMed
Article
Google Scholar
Aronow WS, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharm Therap. 1975;17:549–54.
PubMed
Article
CAS
Google Scholar
Gottschalk LA, Aronow WS, Prakash R. Effect of marijuana and placebo-marijuana smoking on psychological state and on psycho-physiological cardiovascular functioning in anginal patients. Biol Psychiatry. 1977;12:255–66.
PubMed
CAS
Google Scholar
Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J. 2008;155:465–70.
PubMed
PubMed Central
Article
Google Scholar
Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352:1611–6.
PubMed
Article
CAS
Google Scholar
Mohan H, Sood GC. Conjugate deviation of the eyes after Cannabis indica intoxication. Br J Ophthalmol. 1964;48:160–1.
PubMed
PubMed Central
Article
CAS
Google Scholar
Jouanjus E, Leymarie F, Tubery M, et al. Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol. 2011;71:758–65.
PubMed
PubMed Central
Article
Google Scholar
Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64:495–502.
PubMed
Article
Google Scholar
Hemachandra D, McKetin R, Cherbuin N, Anstey KJ. Heavy cannabis users at elevated risk of stroke: evidence from a general population survey. Aust N Z J Public Health. 2016;40:226–30.
PubMed
Article
Google Scholar
Rumalla K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States. J Neurol Sci. 2016;364:191–6.
PubMed
Article
Google Scholar
Phillips MC, Leyden JM, Chong WK, et al. Ischaemic stroke among young people aged 15 to 50 years in Adelaide, South Australia. Med J Aust. 2011;195:610–4.
PubMed
Article
Google Scholar
de los Ríos F, Kleindorfer DO, Khoury J, et al. Trends in substance abuse preceding stroke among young adults: a population based study. Stroke. 2012;43:3179–83.
PubMed
Article
CAS
Google Scholar
Wolff V, Armspach JP, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke. 2013;44:558–63.
PubMed
Article
Google Scholar
Singh NN, Pan Y, Muengtaweeponsa S, Geller TJ, Cruz-Flores S. Cannabis-related stroke: case series and review of literature. J Stroke Cerebrovasc Dis. 2012;21:555–60.
PubMed
Article
Google Scholar
Finsterer J, Christian P, Wolfgang K. Occipital stroke shortly after cannabis consumption. Clin Neurol Neurosurg. 2004;106:305–8.
PubMed
Article
Google Scholar
Santos AF, Rodriguez M, Maré R, Ferreira C, Soares-Fernandes J, Rocha J. Recurrent stroke in a young cannabis user. J Neuropsychiatry Clin Neurosci. 2014;26:41–2.
Article
Google Scholar
Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how “safe” is it? Eur Neurol. 2000;44:42–4.
PubMed
Article
CAS
Google Scholar
Melki E, Denier C, Théaudin-Saliou M, Sachet M, Ducreux D, Saliou G. External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome. J Neurol Sci. 2012;313:46–7.
PubMed
Article
CAS
Google Scholar
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.
PubMed
Article
Google Scholar
Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction a prospective study in 48 consecutive young patients. Stroke. 2011;42:1778–80.
PubMed
Article
Google Scholar
Uhegwu N, Bashir A, Hussain M, Dababneh H, Misthal S, Cohen-Gadol A. Marijuana induced reversible cerebral vasoconstriction syndrome. J Vasc Interv Neurol. 2015;8:36–8.
PubMed
PubMed Central
Google Scholar
Herning RI, Better WE, Tate K, Cadet JL. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64:488–93.
PubMed
Article
Google Scholar
Wolff V, Zinchenko I, Quenardelle V, Rouyer O, Geny B. Characteristics and prognosis of ischemic stroke in young cannabis users compared with non-cannabis users. J Am Coll Cardiol. 2015;66:2052–3.
PubMed
Article
Google Scholar
Renard D, Taieb G, Gras-Combe G, Labauge P. Cannabis-related myocardial infarction and cardioembolic stroke. J Stroke Cerebrovasc Dis. 2012;21:82–3.
PubMed
Article
Google Scholar
Volpon LC, Sousa CLMM, Moreira SKK, Teixeira SR, Carlotti APCP. Multiple cerebral infarcts in a young patient associated with marijuana use. J Addict Med. 2017;11:405–7.
PubMed
Article
Google Scholar
Shah M, Garg J, Patel B, Guthier J, Freudenberger RS. Can your heart handle the spice: a case of acute myocardial infarction and left ventricular apical thrombus. Int J Cardiol. 2016;215:129–31.
PubMed
Article
Google Scholar
Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in hemorrhagic shock. Nature. 1997;390:518–21.
PubMed
Article
CAS
Google Scholar
Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 1998;12:1035–44.
PubMed
Article
CAS
Google Scholar
Godlewski G, Malinowska B, Schlicker E. Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats. Br J Pharmacol. 2004;142:701–8.
PubMed
PubMed Central
Article
CAS
Google Scholar
Kaushik M, Alla VM, Madan R, Arouni AJ, Mohiuddin SM. Recurrent stress cardiomyopathy with variable regional involvement: insights into etiopathogenetic mechanisms. Circulation. 2011;124:e556–7.
PubMed
Article
Google Scholar
Bonz A, Laser M, Küllmer S, et al. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J Cardiovasc Pharmacol. 2003;41:657–64.
PubMed
Article
CAS
Google Scholar
Mukhopadhyay P, Bátkai S, Rajesh M, et al. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol. 2007;50:528–36.
PubMed
PubMed Central
Article
CAS
Google Scholar
Pacher P, Bátkai S, Kunos G. Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol. 2005;168:599–625.
Article
CAS
Google Scholar
Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002;42(S1):64S–70S.
PubMed
Article
CAS
Google Scholar
Kalla A, Krishnamoorthy P, Gopalakrishnan A, Garg J, Figueredo V. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the national inpatient sample. J Am Coll Cardiol. 2017;69(11(Suppl)):1784 (abstract).
Article
Google Scholar
Nogi M, Fergusson D, Chiaco JM. Mid-ventricular variant takotsubo cardiomyopathy associated with cannabinoid hyperemesis syndrome: a case report. Hawaii J Med Public Health. 2014;73:115–8.
PubMed
PubMed Central
Google Scholar
Singh A, Agrawal S, Fegley M, Manda Y, Nanda S, Shirani J. Marijuana (cannabis) use is an independent predictor of stress cardiomyopathy in younger men. Circulation. 2016;134:A14100.
Google Scholar
Pacher P, Mukhopadhyay P, Mohanraj R, Godlewski G, Bátkai S, Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52:601–7.
PubMed
PubMed Central
Article
CAS
Google Scholar
Elsheshtawy M, Sriganesh P, Virparia V, Patel F, Khanna A. Synthetic marijuana induced acute nonischemic left ventricular dysfunction. Case Rep Cardiol. 2016;2016:4. https://doi.org/10.1155/2016/9625758.
Article
Google Scholar
Petronis KR, Anthony JC. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend. 1989;23:219–26.
PubMed
Article
CAS
Google Scholar
Kiplinger GF, Manno JE. Dose-response relationships to cannabis in human subjects. Pharmacol Rev. 1971;23:339–47.
PubMed
CAS
Google Scholar
Daisley H, Jones-Le Cointe A, Hutchinson G, Simmons V. Fatal cardiac toxicity temporally related to poly-drug abuse. Vet Hum Toxicol. 1998;40:21–2.
PubMed
CAS
Google Scholar
Bachs L, Mørland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int. 2001;124:200–3.
PubMed
Article
CAS
Google Scholar
Montisci M, Thiene G, Ferrara SD, Basso C. Cannabis and cocaine: a lethal cocktail triggering coronary sudden death. Cardiovasc Pathol. 2008;17:344–6.
PubMed
Article
CAS
Google Scholar
Fernández- Fernández FJ, Caínzos-Romero T, Mesías Prego A, Sesma P. Ectopic atrial rhythm associated with cannabis use. Minerva Cardioangiol. 2011;59:119–20.
PubMed
Google Scholar
Hartung B, Kauferstein S, Ritz-Timme S, Daldrup T. Sudden unexpected death under acute influence of cannabis. Forensic Sci Int. 2014;237:e11–3.
PubMed
Article
Google Scholar
Korantzopoulos P, Liu T, Papaioannides D, Li G, Goudevenos JA. Atrial fibrillation and marijuana smoking. Int J Clin Pract. 2008;62:308–13.
PubMed
Article
CAS
Google Scholar
Krishnamoorthy S, Lip GY, Lane DA. Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. Am J Med. 2009;122:851–6.
PubMed
Article
CAS
Google Scholar
Miller RH, Dhingra RC, Kanakis C, Amat-y-Leon F, Rosen KM. The electrophysiological effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac conduction in man. Am Heart J. 1977;94:740–7.
PubMed
Article
CAS
Google Scholar
Orsini J, Blaak C, Rajayer S, Gurung V, Tam E, Morante J, Shamian B, Malik R. Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption. J Community Hosp Intern Med Perspect. 2016;. https://doi.org/10.3402/jchimp.v6.31695.
Article
PubMed
PubMed Central
Google Scholar
Fisher BAC, Ghuran A, Vadamalai V, Antonios TF. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J. 2005;22:679–80.
PubMed
PubMed Central
Article
CAS
Google Scholar
Korantzopoulos P. Marijuana smoking is associated with atrial fibrillation. Am J Cardiol. 2014;113:1085–6.
PubMed
Article
Google Scholar
Sterne J, Ducasting G. Les artérites du Cannabis indica. Arch Mal Cœur. 1960;53:143–7.
PubMed
CAS
Google Scholar
Bucci F, Redler A, Fiengo L. Critical limb ischemia in a young man: saddle embolism or unusual presentation of thromboangiitis obliterans? Case Rep Vasc Med. 2013;2013:4. https://doi.org/10.1155/2013/830540.
Article
Google Scholar
Broz P, Jaeger KA. Images in vascular medicine—Buerger’s disease. Vasc Med. 2012;17:366–7.
PubMed
Article
Google Scholar
Ibrir M, Ouadahi N, Hamzaoui N, Zemmour D, Ghita DH, Habouchi A, et al. Peripheral arteritis disease and ischemic strokes in cannabis use: a case report. Thromb Res. 2014;133:S115–6.
Article
Google Scholar
Roberts JA, Meyer J-P. Buerger’s disease presenting as a testicular mass: a rare presentation of an uncommon disease. Urol Ann. 2016;8:249–51.
PubMed
PubMed Central
Article
CAS
Google Scholar
Combemale P, Consort T, Denis-Thelis L, Estival JL, Dupin M, Kanitakis J. Cannabis arteritis. Br J Dermatol. 2005;152:166–9.
PubMed
Article
CAS
Google Scholar
Cottencin O, Karila L, Lambert M, Arveiller C, Benyamina A, Boissonas A, Goudemand M, Reynaud M. Cannabis arteritis: review of the literature. J Addict Med. 2010;4:191–6.
PubMed
Article
CAS
Google Scholar
Leithauser B, Langheinrich AC, Rau WS, Tillmanns H, Matthias FR. A 22-year-old woman with lower limb arteriopathy: Buerger’s disease, or methamphetamine or cannabis-induced arteritis? Heart Vessels. 2005;20:39–43.
PubMed
Article
Google Scholar
Peyrot I, Garsaud AM, Saint-Cyr I, Quitman O, Sanchez B, Quist D. Cannabis arteritis: a new case report and a review of the literature. J Eur Acad Dermatol Venereol. 2007;21:388–91.
PubMed
Article
CAS
Google Scholar
Nahas GG. Cannabis arteritis. N Engl J Med. 1971;284:113.
Cazalets C, Laurat E, Cador B, et al. Arteriopathies du cannabis: quatre nouveaux cas [Cannabis arteritis: four new cases]. Rev Med Intern. 2003;24:127–30.
Article
CAS
Google Scholar
Martin-Blondel G, Koskas F, Cacoub P, Sène D. Is thrombangitis obliterans presentation influenced by cannabis addiction? Ann Vasc Surg. 2011;25:469–73.
PubMed
Article
Google Scholar
Noel B, Ruf I, Panizzon RG. Cannabis arteritis. J Am Acad Dermatol. 2008;58(Suppl 1):S65–7.
PubMed
Article
Google Scholar
Schneider F, Abdoucheli-Baudot N, Tassart M, et al. Cannabis and tobacco: cofactors favoring juvenile obliterative arteriopathy. J Mal Vasc. 2000;25:388–9.
PubMed
CAS
Google Scholar
Santos RP, Resende CI, Vieira AP, Brito C. Cannabis arteritis: ever more important to consider. BMJ Case Rep. 2017;2017. https://doi.org/10.1136/bcr-2016-219111.
Article
PubMed
PubMed Central
Google Scholar
Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited—ten new case reports. Angiology. 2001;52:1–5.
PubMed
Article
CAS
Google Scholar
Lee C, Moll S. Migratory superficial thrombophlebitis in a cannabis smoker. Circulation. 2014;130:214–5.
PubMed
Article
Google Scholar
Lou JY, Randhawa MS, Hornacek D, Bajzer C. Spontaneous renal artery dissection in a cannabis user. Vasc Med. 2015;20:379–80.
PubMed
Article
Google Scholar
Corvi F, Querques G, Lattanzio R, Preziosa C, Parodi MB, Bandello F. Central retinal vein occlusion in a young patients following cannabis smoke inhalation. Eur J Ophthalmol. 2014;24(3):437–40.
PubMed
Article
Google Scholar